APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Valsartan

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Valsartan Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174045020330 December 2025191 pages

Choose your research edition.

Industry ResearchValsartan Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Valsartan Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Valsartan Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Valsartan Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Valsartan Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Valsartan market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Valsartan is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Valsartan is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Valsartan is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Valsartan is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Valsartan include Alembic Pharmaceuticals, Amneal Pharmaceuticals, Aurobindo Pharma, HETERO, Huaren Pharmaceutical, Jubilant Pharma, LG Life Sciences, Lupin and Macleods Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Valsartan market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Valsartan and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Valsartan sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Valsartan market size, projected growth trends, production technologies, key applications, and end-use industries.

Valsartan Segment by Company

Alembic Pharmaceuticals

Amneal Pharmaceuticals

Aurobindo Pharma

HETERO

Huaren Pharmaceutical

Jubilant Pharma

LG Life Sciences

Lupin

Macleods Pharmaceuticals

Square Pharmaceuticals

Torrent Pharmaceuticals

Unichem Laboratories

Mylan

Novartis

Sun Pharmaceutical

Teva

Zhejiang Huahai Pharmaceutical

Valsartan Segment by Type

80 mg Tablets

40 mg Tablets

320 mg Tablets

160 mg Tablets

Valsartan Segment by Application

Heart Failure

Heart Attack

Hypertension

Valsartan Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valsartan market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Valsartan and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valsartan.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Valsartan market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Valsartan manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Valsartan in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Valsartan in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Valsartan Industry Trends Table 2. Valsartan Industry Drivers Table 3. Valsartan Industry Opportunities and Challenges Table 4. Valsartan Industry Restraints Table 5. Global Valsartan Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Valsartan Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Valsartan Sales by Manufacturers (K Pcs) & (2021-2026) Table 8. Global Valsartan Sales Market Share by Manufacturers Table 9. Global Valsartan Average Sales Price (US$/Pcs) of Manufacturers (2021-2026) Table 10. Global Valsartan Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Valsartan Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Valsartan Manufacturers, Product Type & Application Table 13. Global Valsartan Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Valsartan by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 80 mg Tablets Table 17. Major Manufacturers of 40 mg Tablets Table 18. Major Manufacturers of 320 mg Tablets Table 19. Major Manufacturers of 160 mg Tablets Table 20. Global Valsartan Sales by Type 2021 VS 2025 VS 2032 (K Pcs) Table 21. Global Valsartan Sales by Type (2021-2026) & (K Pcs) Table 22. Global Valsartan Sales by Type (2027-2032) & (K Pcs) Table 23. Global Valsartan Sales Market Share by Type (2021-2026) Table 24. Global Valsartan Sales Market Share by Type (2027-2032) Table 25. Global Valsartan Revenue by Type 2021 VS 2025 VS 2032 (K Pcs) Table 26. Global Valsartan Revenue by Type (2021-2026) & (K Pcs) Table 27. Global Valsartan Revenue by Type (2027-2032) & (K Pcs) Table 28. Global Valsartan Revenue Market Share by Type (2021-2026) Table 29. Global Valsartan Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Heart Failure Table 31. Major Manufacturers of Heart Attack Table 32. Major Manufacturers of Hypertension Table 33. Global Valsartan Sales by Application 2021 VS 2025 VS 2032 (K Pcs) Table 34. Global Valsartan Sales by Application (2021-2026) & (K Pcs) Table 35. Global Valsartan Sales by Application (2027-2032) & (K Pcs) Table 36. Global Valsartan Sales Market Share by Application (2021-2026) Table 37. Global Valsartan Sales Market Share by Application (2027-2032) Table 38. Global Valsartan Revenue by Application 2021 VS 2025 VS 2032 (K Pcs) Table 39. Global Valsartan Revenue by Application (2021-2026) & (K Pcs) Table 40. Global Valsartan Revenue by Application (2027-2032) & (K Pcs) Table 41. Global Valsartan Revenue Market Share by Application (2021-2026) Table 42. Global Valsartan Revenue Market Share by Application (2027-2032) Table 43. Global Valsartan Sales by Region: 2021 VS 2025 VS 2032 (K Pcs) Table 44. Global Valsartan Sales by Region (2021-2026) & (K Pcs) Table 45. Global Valsartan Sales Market Share by Region (2021-2026) Table 46. Global Valsartan Sales Forecasted by Region (2027-2032) & (K Pcs) Table 47. Global Valsartan Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Valsartan Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 49. North America Valsartan Sales by Country (2021-2026) & (K Pcs) Table 50. North America Valsartan Sales by Country (2027-2032) & (K Pcs) Table 51. Europe Valsartan Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 52. Europe Valsartan Sales by Country (2021-2026) & (K Pcs) Table 53. Europe Valsartan Sales by Country (2027-2032) & (K Pcs) Table 54. Asia Pacific Valsartan Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 55. Asia Pacific Valsartan Sales by Country (2021-2026) & (K Pcs) Table 56. Asia Pacific Valsartan Sales by Country (2027-2032) & (K Pcs) Table 57. South America, Middle East and Africa Valsartan Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 58. South America, Middle East and Africa Valsartan Sales by Country (2021-2026) & (K Pcs) Table 59. South America, Middle East and Africa Valsartan Sales by Country (2027-2032) & (K Pcs) Table 60. Global Valsartan Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Valsartan Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Valsartan Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Valsartan Revenue Market Share by Region (2021-2026) Table 64. Global Valsartan Revenue Market Share by Region (2027-2032) Table 65. Alembic Pharmaceuticals Company Information Table 66. Alembic Pharmaceuticals Business Overview Table 67. Alembic Pharmaceuticals Valsartan Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Alembic Pharmaceuticals Valsartan Product Portfolio Table 69. Alembic Pharmaceuticals Recent Development Table 70. Amneal Pharmaceuticals Company Information Table 71. Amneal Pharmaceuticals Business Overview Table 72. Amneal Pharmaceuticals Valsartan Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Amneal Pharmaceuticals Valsartan Product Portfolio Table 74. Amneal Pharmaceuticals Recent Development Table 75. Aurobindo Pharma Company Information Table 76. Aurobindo Pharma Business Overview Table 77. Aurobindo Pharma Valsartan Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Aurobindo Pharma Valsartan Product Portfolio Table 79. Aurobindo Pharma Recent Development Table 80. HETERO Company Information Table 81. HETERO Business Overview Table 82. HETERO Valsartan Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. HETERO Valsartan Product Portfolio Table 84. HETERO Recent Development Table 85. Huaren Pharmaceutical Company Information Table 86. Huaren Pharmaceutical Business Overview Table 87. Huaren Pharmaceutical Valsartan Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Huaren Pharmaceutical Valsartan Product Portfolio Table 89. Huaren Pharmaceutical Recent Development Table 90. Jubilant Pharma Company Information Table 91. Jubilant Pharma Business Overview Table 92. Jubilant Pharma Valsartan Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Jubilant Pharma Valsartan Product Portfolio Table 94. Jubilant Pharma Recent Development Table 95. LG Life Sciences Company Information Table 96. LG Life Sciences Business Overview Table 97. LG Life Sciences Valsartan Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. LG Life Sciences Valsartan Product Portfolio Table 99. LG Life Sciences Recent Development Table 100. Lupin Company Information Table 101. Lupin Business Overview Table 102. Lupin Valsartan Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Lupin Valsartan Product Portfolio Table 104. Lupin Recent Development Table 105. Macleods Pharmaceuticals Company Information Table 106. Macleods Pharmaceuticals Business Overview Table 107. Macleods Pharmaceuticals Valsartan Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Macleods Pharmaceuticals Valsartan Product Portfolio Table 109. Macleods Pharmaceuticals Recent Development Table 110. Square Pharmaceuticals Company Information Table 111. Square Pharmaceuticals Business Overview Table 112. Square Pharmaceuticals Valsartan Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Square Pharmaceuticals Valsartan Product Portfolio Table 114. Square Pharmaceuticals Recent Development Table 115. Torrent Pharmaceuticals Company Information Table 116. Torrent Pharmaceuticals Business Overview Table 117. Torrent Pharmaceuticals Valsartan Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Torrent Pharmaceuticals Valsartan Product Portfolio Table 119. Torrent Pharmaceuticals Recent Development Table 120. Unichem Laboratories Company Information Table 121. Unichem Laboratories Business Overview Table 122. Unichem Laboratories Valsartan Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Unichem Laboratories Valsartan Product Portfolio Table 124. Unichem Laboratories Recent Development Table 125. Mylan Company Information Table 126. Mylan Business Overview Table 127. Mylan Valsartan Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Mylan Valsartan Product Portfolio Table 129. Mylan Recent Development Table 130. Novartis Company Information Table 131. Novartis Business Overview Table 132. Novartis Valsartan Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Novartis Valsartan Product Portfolio Table 134. Novartis Recent Development Table 135. Sun Pharmaceutical Company Information Table 136. Sun Pharmaceutical Business Overview Table 137. Sun Pharmaceutical Valsartan Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Sun Pharmaceutical Valsartan Product Portfolio Table 139. Sun Pharmaceutical Recent Development Table 140. Teva Company Information Table 141. Teva Business Overview Table 142. Teva Valsartan Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. Teva Valsartan Product Portfolio Table 144. Teva Recent Development Table 145. Zhejiang Huahai Pharmaceutical Company Information Table 146. Zhejiang Huahai Pharmaceutical Business Overview Table 147. Zhejiang Huahai Pharmaceutical Valsartan Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. Zhejiang Huahai Pharmaceutical Valsartan Product Portfolio Table 149. Zhejiang Huahai Pharmaceutical Recent Development Table 150. Key Raw Materials Table 151. Raw Materials Key Suppliers Table 152. Valsartan Distributors List Table 153. Valsartan Customers List Table 154. Research Programs/Design for This Report Table 155. Authors List of This Report Table 156. Secondary Sources Table 157. Primary Sources List of Figures Figure 1. Valsartan Product Image Figure 2. Global Valsartan Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Valsartan Market Size (2021-2032) & (US$ Million) Figure 4. Global Valsartan Sales (2021-2032) & (K Pcs) Figure 5. Global Valsartan Average Price (US$/Pcs) & (2021-2032) Figure 6. Global Top 5 and 10 Valsartan Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 80 mg Tablets Image Figure 9. 40 mg Tablets Image Figure 10. 320 mg Tablets Image Figure 11. 160 mg Tablets Image Figure 12. Global Valsartan Sales by Type (2021 VS 2025 VS 2032) & (K Pcs) Figure 13. Global Valsartan Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Valsartan Sales Market Share by Type (2021-2032) Figure 15. Global Valsartan Revenue by Type (2021 VS 2025 VS 2032) & (K Pcs) Figure 16. Global Valsartan Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Valsartan Revenue Market Share by Type (2021-2032) Figure 18. Heart Failure Image Figure 19. Heart Attack Image Figure 20. Hypertension Image Figure 21. Global Valsartan Sales by Application (2021 VS 2025 VS 2032) & (K Pcs) Figure 22. Global Valsartan Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Valsartan Sales Market Share by Application (2021-2032) Figure 24. Global Valsartan Revenue by Application (2021 VS 2025 VS 2032) & (K Pcs) Figure 25. Global Valsartan Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Valsartan Revenue Market Share by Application (2021-2032) Figure 27. North America Valsartan Sales and Growth Rate (2021-2032) & (K Pcs) Figure 28. North America Valsartan Sales Market Share by Country (2021-2032) Figure 29. U.S. Valsartan Sales and Growth Rate (2021-2032) & (K Pcs) Figure 30. Canada Valsartan Sales and Growth Rate (2021-2032) & (K Pcs) Figure 31. Mexico Valsartan Sales and Growth Rate (2021-2032) & (K Pcs) Figure 32. Europe Valsartan Sales and Growth Rate (2021-2032) & (K Pcs) Figure 33. Europe Valsartan Sales Market Share by Country (2021-2032) Figure 34. Germany Valsartan Sales and Growth Rate (2021-2032) & (K Pcs) Figure 35. France Valsartan Sales and Growth Rate (2021-2032) & (K Pcs) Figure 36. U.K. Valsartan Sales and Growth Rate (2021-2032) & (K Pcs) Figure 37. Italy Valsartan Sales and Growth Rate (2021-2032) & (K Pcs) Figure 38. Netherlands Valsartan Sales and Growth Rate (2021-2032) & (K Pcs) Figure 39. Asia Pacific Valsartan Sales and Growth Rate (2021-2032) & (K Pcs) Figure 40. Asia Pacific Valsartan Sales Market Share by Country (2021-2032) Figure 41. China Valsartan Sales and Growth Rate (2021-2032) & (K Pcs) Figure 42. Japan Valsartan Sales and Growth Rate (2021-2032) & (K Pcs) Figure 43. South Korea Valsartan Sales and Growth Rate (2021-2032) & (K Pcs) Figure 44. Southeast Asia Valsartan Sales and Growth Rate (2021-2032) & (K Pcs) Figure 45. India Valsartan Sales and Growth Rate (2021-2032) & (K Pcs) Figure 46. Australia Valsartan Sales and Growth Rate (2021-2032) & (K Pcs) Figure 47. South America, Middle East and Africa Valsartan Sales and Growth Rate (2021-2032) & (K Pcs) Figure 48. South America, Middle East and Africa Valsartan Sales Market Share by Country (2021-2032) Figure 49. Brazil Valsartan Sales and Growth Rate (2021-2032) & (K Pcs) Figure 50. South Africa Valsartan Sales and Growth Rate (2021-2032) & (K Pcs) Figure 51. Saudi Arabia Valsartan Sales and Growth Rate (2021-2032) & (K Pcs) Figure 52. Turkey Valsartan Sales and Growth Rate (2021-2032) & (K Pcs) Figure 53. Argentina Valsartan Sales and Growth Rate (2021-2032) & (K Pcs) Figure 54. UAE Valsartan Sales and Growth Rate (2021-2032) & (K Pcs) Figure 55. Egypt Valsartan Sales and Growth Rate (2021-2032) & (K Pcs) Figure 56. Chile Valsartan Sales and Growth Rate (2021-2032) & (K Pcs) Figure 57. Global Valsartan Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Valsartan Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Valsartan Revenue (2021-2032) & (US$ Million) Figure 60. North America Valsartan Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Valsartan Revenue (2021-2032) & (US$ Million) Figure 62. Europe Valsartan Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Valsartan Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Valsartan Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Valsartan Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Valsartan Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Valsartan Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Valsartan Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 80 mg Tablets
  • 40 mg Tablets
  • 320 mg Tablets
  • 160 mg Tablets
Applications
  • Heart Failure
  • Heart Attack
  • Hypertension
Companies covered
  • Alembic Pharmaceuticals
  • Amneal Pharmaceuticals
  • Aurobindo Pharma
  • HETERO
  • Huaren Pharmaceutical
  • Jubilant Pharma
  • LG Life Sciences
  • Lupin
  • Macleods Pharmaceuticals
  • Square Pharmaceuticals
  • Torrent Pharmaceuticals
  • Unichem Laboratories
  • Mylan
  • Novartis
  • Sun Pharmaceutical
  • Teva
  • Zhejiang Huahai Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Valsartan Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Valsartan Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Valsartan Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Valsartan Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Valsartan Market Dynamics
  1. 2.1 Valsartan Industry Trends
  2. 2.2 Valsartan Industry Drivers
  3. 2.3 Valsartan Industry Opportunities and Challenges
  4. 2.4 Valsartan Industry Restraints
3 Valsartan Market by Manufacturers
  1. 3.1 Global Valsartan Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Valsartan Sales by Manufacturers (2021-2026)
  3. 3.3 Global Valsartan Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Valsartan Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Valsartan Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Valsartan Manufacturers, Product Type & Application
  7. 3.7 Global Valsartan Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Valsartan Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Valsartan Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Valsartan Tier 1, Tier 2, and Tier 3
4 Valsartan Market by Type
  1. 4.1 Valsartan Type Introduction
  2. 4.1.1 80 mg Tablets
  3. 4.1.2 40 mg Tablets
  4. 4.1.3 320 mg Tablets
  5. 4.1.4 160 mg Tablets
  6. 4.2 Global Valsartan Sales by Type
  7. 4.2.1 Global Valsartan Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Valsartan Sales by Type (2021-2032)
  9. 4.2.3 Global Valsartan Sales Market Share by Type (2021-2032)
  10. 4.3 Global Valsartan Revenue by Type
  11. 4.3.1 Global Valsartan Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Valsartan Revenue by Type (2021-2032)
  13. 4.3.3 Global Valsartan Revenue Market Share by Type (2021-2032)
5 Valsartan Market by Application
  1. 5.1 Valsartan Application Introduction
  2. 5.1.1 Heart Failure
  3. 5.1.2 Heart Attack
  4. 5.1.3 Hypertension
  5. 5.2 Global Valsartan Sales by Application
  6. 5.2.1 Global Valsartan Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Valsartan Sales by Application (2021-2032)
  8. 5.2.3 Global Valsartan Sales Market Share by Application (2021-2032)
  9. 5.3 Global Valsartan Revenue by Application
  10. 5.3.1 Global Valsartan Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Valsartan Revenue by Application (2021-2032)
  12. 5.3.3 Global Valsartan Revenue Market Share by Application (2021-2032)
6 Global Valsartan Sales by Region
  1. 6.1 Global Valsartan Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Valsartan Sales by Region (2021-2032)
  3. 6.2.1 Global Valsartan Sales by Region (2021-2026)
  4. 6.2.2 Global Valsartan Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Valsartan Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Valsartan Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Valsartan Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Valsartan Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Valsartan Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Valsartan Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Valsartan Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Valsartan Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Valsartan Revenue by Region
  1. 7.1 Global Valsartan Revenue by Region
  2. 7.1.1 Global Valsartan Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Valsartan Revenue by Region (2021-2026)
  4. 7.1.3 Global Valsartan Revenue by Region (2027-2032)
  5. 7.1.4 Global Valsartan Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Valsartan Revenue (2021-2032)
  8. 7.2.2 North America Valsartan Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Valsartan Revenue (2021-2032)
  11. 7.3.2 Europe Valsartan Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Valsartan Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Valsartan Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Valsartan Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Valsartan Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Alembic Pharmaceuticals
  2. 8.1.1 Alembic Pharmaceuticals Company Information
  3. 8.1.2 Alembic Pharmaceuticals Business Overview
  4. 8.1.3 Alembic Pharmaceuticals Valsartan Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Alembic Pharmaceuticals Valsartan Product Portfolio
  6. 8.1.5 Alembic Pharmaceuticals Recent Developments
  7. 8.2 Amneal Pharmaceuticals
  8. 8.2.1 Amneal Pharmaceuticals Company Information
  9. 8.2.2 Amneal Pharmaceuticals Business Overview
  10. 8.2.3 Amneal Pharmaceuticals Valsartan Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Amneal Pharmaceuticals Valsartan Product Portfolio
  12. 8.2.5 Amneal Pharmaceuticals Recent Developments
  13. 8.3 Aurobindo Pharma
  14. 8.3.1 Aurobindo Pharma Company Information
  15. 8.3.2 Aurobindo Pharma Business Overview
  16. 8.3.3 Aurobindo Pharma Valsartan Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Aurobindo Pharma Valsartan Product Portfolio
  18. 8.3.5 Aurobindo Pharma Recent Developments
  19. 8.4 HETERO
  20. 8.4.1 HETERO Company Information
  21. 8.4.2 HETERO Business Overview
  22. 8.4.3 HETERO Valsartan Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 HETERO Valsartan Product Portfolio
  24. 8.4.5 HETERO Recent Developments
  25. 8.5 Huaren Pharmaceutical
  26. 8.5.1 Huaren Pharmaceutical Company Information
  27. 8.5.2 Huaren Pharmaceutical Business Overview
  28. 8.5.3 Huaren Pharmaceutical Valsartan Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Huaren Pharmaceutical Valsartan Product Portfolio
  30. 8.5.5 Huaren Pharmaceutical Recent Developments
  31. 8.6 Jubilant Pharma
  32. 8.6.1 Jubilant Pharma Company Information
  33. 8.6.2 Jubilant Pharma Business Overview
  34. 8.6.3 Jubilant Pharma Valsartan Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Jubilant Pharma Valsartan Product Portfolio
  36. 8.6.5 Jubilant Pharma Recent Developments
  37. 8.7 LG Life Sciences
  38. 8.7.1 LG Life Sciences Company Information
  39. 8.7.2 LG Life Sciences Business Overview
  40. 8.7.3 LG Life Sciences Valsartan Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 LG Life Sciences Valsartan Product Portfolio
  42. 8.7.5 LG Life Sciences Recent Developments
  43. 8.8 Lupin
  44. 8.8.1 Lupin Company Information
  45. 8.8.2 Lupin Business Overview
  46. 8.8.3 Lupin Valsartan Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Lupin Valsartan Product Portfolio
  48. 8.8.5 Lupin Recent Developments
  49. 8.9 Macleods Pharmaceuticals
  50. 8.9.1 Macleods Pharmaceuticals Company Information
  51. 8.9.2 Macleods Pharmaceuticals Business Overview
  52. 8.9.3 Macleods Pharmaceuticals Valsartan Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Macleods Pharmaceuticals Valsartan Product Portfolio
  54. 8.9.5 Macleods Pharmaceuticals Recent Developments
  55. 8.10 Square Pharmaceuticals
  56. 8.10.1 Square Pharmaceuticals Company Information
  57. 8.10.2 Square Pharmaceuticals Business Overview
  58. 8.10.3 Square Pharmaceuticals Valsartan Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Square Pharmaceuticals Valsartan Product Portfolio
  60. 8.10.5 Square Pharmaceuticals Recent Developments
  61. 8.11 Torrent Pharmaceuticals
  62. 8.11.1 Torrent Pharmaceuticals Company Information
  63. 8.11.2 Torrent Pharmaceuticals Business Overview
  64. 8.11.3 Torrent Pharmaceuticals Valsartan Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Torrent Pharmaceuticals Valsartan Product Portfolio
  66. 8.11.5 Torrent Pharmaceuticals Recent Developments
  67. 8.12 Unichem Laboratories
  68. 8.12.1 Unichem Laboratories Company Information
  69. 8.12.2 Unichem Laboratories Business Overview
  70. 8.12.3 Unichem Laboratories Valsartan Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Unichem Laboratories Valsartan Product Portfolio
  72. 8.12.5 Unichem Laboratories Recent Developments
  73. 8.13 Mylan
  74. 8.13.1 Mylan Company Information
  75. 8.13.2 Mylan Business Overview
  76. 8.13.3 Mylan Valsartan Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Mylan Valsartan Product Portfolio
  78. 8.13.5 Mylan Recent Developments
  79. 8.14 Novartis
  80. 8.14.1 Novartis Company Information
  81. 8.14.2 Novartis Business Overview
  82. 8.14.3 Novartis Valsartan Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Novartis Valsartan Product Portfolio
  84. 8.14.5 Novartis Recent Developments
  85. 8.15 Sun Pharmaceutical
  86. 8.15.1 Sun Pharmaceutical Company Information
  87. 8.15.2 Sun Pharmaceutical Business Overview
  88. 8.15.3 Sun Pharmaceutical Valsartan Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Sun Pharmaceutical Valsartan Product Portfolio
  90. 8.15.5 Sun Pharmaceutical Recent Developments
  91. 8.16 Teva
  92. 8.16.1 Teva Company Information
  93. 8.16.2 Teva Business Overview
  94. 8.16.3 Teva Valsartan Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Teva Valsartan Product Portfolio
  96. 8.16.5 Teva Recent Developments
  97. 8.17 Zhejiang Huahai Pharmaceutical
  98. 8.17.1 Zhejiang Huahai Pharmaceutical Company Information
  99. 8.17.2 Zhejiang Huahai Pharmaceutical Business Overview
  100. 8.17.3 Zhejiang Huahai Pharmaceutical Valsartan Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Zhejiang Huahai Pharmaceutical Valsartan Product Portfolio
  102. 8.17.5 Zhejiang Huahai Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Valsartan Value Chain Analysis
  2. 9.1.1 Valsartan Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Valsartan Production Mode & Process
  6. 9.2 Valsartan Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Valsartan Distributors
  9. 9.2.3 Valsartan Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst